位置:首页 > 蛋白库 > ATNA_DROME
ATNA_DROME
ID   ATNA_DROME              Reviewed;        1041 AA.
AC   P13607; A4V366; A4V367; O61494; Q0KI37; Q7KS94; Q7KS95; Q86MY6; Q86MY7;
AC   Q86MY8; Q86MY9; Q86MZ0; Q8IN40; Q8T0L8; Q9VDG6; Q9VDG7; Q9VDG8;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2001, sequence version 3.
DT   03-AUG-2022, entry version 216.
DE   RecName: Full=Sodium/potassium-transporting ATPase subunit alpha;
DE            Short=Na(+)/K(+) ATPase alpha subunit;
DE            EC=7.2.2.13 {ECO:0000305|PubMed:9648860};
DE   AltName: Full=Sodium pump subunit alpha;
GN   Name=Atpalpha; Synonyms=Na-p; ORFNames=CG5670;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Canton-S, and Oregon-R; TISSUE=Embryo, Head, and Pupae;
RX   PubMed=2540956; DOI=10.1002/j.1460-2075.1989.tb03364.x;
RA   Lebovitz R.M., Takeyasu K., Fambrough D.M.;
RT   "Molecular characterization and expression of the (Na+ + K+)-ATPase alpha-
RT   subunit in Drosophila melanogaster.";
RL   EMBO J. 8:193-202(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Head;
RX   PubMed=9648860; DOI=10.1046/j.1471-4159.1998.71010142.x;
RA   Sun B., Wang W., Salvaterra P.M.;
RT   "Functional analysis and tissue-specific expression of Drosophila Na+,K+-
RT   ATPase subunits.";
RL   J. Neurochem. 71:142-151(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND RNA EDITING OF
RP   POSITION 429.
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-35 (ISOFORM 4), NUCLEOTIDE SEQUENCE
RP   [GENOMIC DNA] OF 835-865 (ISOFORMS 1; 5; 6 AND 7), FUNCTION, AND
RP   MUTAGENESIS OF ASP-1020 AND GLU-1021.
RX   PubMed=12598616; DOI=10.1523/jneurosci.23-04-01276.2003;
RA   Palladino M.J., Bower J.E., Kreber R., Ganetzky B.;
RT   "Neural dysfunction and neurodegeneration in Drosophila Na+/K+ ATPase alpha
RT   subunit mutants.";
RL   J. Neurosci. 23:1276-1286(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-8.
RX   PubMed=9680312; DOI=10.1046/j.1365-4624.1997.00006.x;
RA   Feng Y., Huynh L., Takeyasu K., Fambrough D.M.;
RT   "The Drosophila Na,K-ATPase alpha-subunit gene: gene structure, promoter
RT   function and analysis of a cold-sensitive recessive-lethal mutation.";
RL   Genes Funct. 1:99-117(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 400-524.
RX   PubMed=2557235; DOI=10.1016/0014-5793(89)81653-9;
RA   Varadi A., Gilmore-Heber M., Benz E.J. Jr.;
RT   "Amplification of the phosphorylation site-ATP-binding site cDNA fragment
RT   of the Na+,K(+)-ATPase and the Ca2(+)-ATPase of Drosophila melanogaster by
RT   polymerase chain reaction.";
RL   FEBS Lett. 258:203-207(1989).
RN   [9]
RP   RNA EDITING OF POSITION 429.
RX   PubMed=17018572; DOI=10.1261/rna.254306;
RA   Stapleton M., Carlson J.W., Celniker S.E.;
RT   "RNA editing in Drosophila melanogaster: new targets and functional
RT   consequences.";
RL   RNA 12:1922-1932(2006).
CC   -!- FUNCTION: This is the catalytic component of the active enzyme, which
CC       catalyzes the hydrolysis of ATP coupled with the exchange of sodium and
CC       potassium ions across the plasma membrane. This action creates the
CC       electrochemical gradient of sodium and potassium ions, providing the
CC       energy for active transport of various nutrients.
CC       {ECO:0000269|PubMed:12598616, ECO:0000269|PubMed:2540956,
CC       ECO:0000269|PubMed:9648860}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + K(+)(out) + Na(+)(in) = ADP + H(+) + K(+)(in) +
CC         Na(+)(out) + phosphate; Xref=Rhea:RHEA:18353, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29101, ChEBI:CHEBI:29103,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         EC=7.2.2.13; Evidence={ECO:0000305|PubMed:9648860};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18354;
CC         Evidence={ECO:0000305|PubMed:9648860};
CC   -!- SUBUNIT: The sodium/potassium-transporting ATPase is composed of a
CC       catalytic alpha subunit, an auxiliary non-catalytic beta subunit and an
CC       additional regulatory subunit. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Exon 6 has 4 mutually exclusive forms (6a, 6b, 6c and 6d).
CC         Additional isoforms may exist.;
CC       Name=1; Synonyms=A;
CC         IsoId=P13607-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, C, E;
CC         IsoId=P13607-2; Sequence=VSP_000417;
CC       Name=3; Synonyms=D;
CC         IsoId=P13607-3; Sequence=VSP_000417, VSP_008077, VSP_008078;
CC       Name=4;
CC         IsoId=P13607-4; Sequence=VSP_008074;
CC       Name=5;
CC         IsoId=P13607-5; Sequence=VSP_008075;
CC       Name=6; Synonyms=F, H;
CC         IsoId=P13607-6; Sequence=VSP_000417, VSP_000418;
CC       Name=7; Synonyms=G;
CC         IsoId=P13607-7; Sequence=VSP_000417, VSP_008076;
CC   -!- TISSUE SPECIFICITY: High levels are found in some adult tissues:
CC       Malpighian tubules, indirect flight muscles, tubular leg muscles and
CC       throughout the nervous system (brain, optic lobes, retina and ventral
CC       thoracic neuromere). Lower levels are detected at the posterior end
CC       where the reproductive organs and rectum are located.
CC       {ECO:0000269|PubMed:2540956, ECO:0000269|PubMed:9648860}.
CC   -!- RNA EDITING: Modified_positions=429 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:17018572}; Note=Partially edited. Target of Adar.;
CC   -!- MISCELLANEOUS: Ouabain-sensitive electrogenic ion pump.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14476; CAA32638.1; -; mRNA.
DR   EMBL; AF044974; AAC05260.1; -; mRNA.
DR   EMBL; AE014297; AAF55825.3; -; Genomic_DNA.
DR   EMBL; AE014297; AAF55826.2; -; Genomic_DNA.
DR   EMBL; AE014297; AAF55828.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAS65183.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAS65184.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAS65185.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAS65186.1; -; Genomic_DNA.
DR   EMBL; AY069184; AAL39329.1; -; mRNA.
DR   EMBL; AY174097; AAO33930.1; -; Genomic_DNA.
DR   EMBL; AY174097; AAO33931.1; -; Genomic_DNA.
DR   EMBL; AY174097; AAO33932.1; -; Genomic_DNA.
DR   EMBL; AY174097; AAO33933.1; -; Genomic_DNA.
DR   EMBL; AY174098; AAO33929.1; -; Genomic_DNA.
DR   EMBL; U55767; AAB01189.1; -; Genomic_DNA.
DR   EMBL; X17471; CAA35504.1; -; mRNA.
DR   PIR; S03632; S03632.
DR   RefSeq; NP_001262790.1; NM_001275861.1. [P13607-2]
DR   RefSeq; NP_001262791.1; NM_001275862.2. [P13607-2]
DR   RefSeq; NP_732572.1; NM_169936.3. [P13607-1]
DR   RefSeq; NP_732573.1; NM_169937.3. [P13607-2]
DR   RefSeq; NP_732574.1; NM_169938.3. [P13607-2]
DR   RefSeq; NP_732575.1; NM_169939.2. [P13607-3]
DR   RefSeq; NP_996247.1; NM_206525.3. [P13607-6]
DR   RefSeq; NP_996248.1; NM_206526.3. [P13607-7]
DR   RefSeq; NP_996249.1; NM_206527.3. [P13607-6]
DR   RefSeq; NP_996250.1; NM_206528.3. [P13607-2]
DR   AlphaFoldDB; P13607; -.
DR   SMR; P13607; -.
DR   BioGRID; 71866; 59.
DR   DIP; DIP-19649N; -.
DR   IntAct; P13607; 36.
DR   STRING; 7227.FBpp0088502; -.
DR   PaxDb; P13607; -.
DR   PRIDE; P13607; -.
DR   DNASU; 48971; -.
DR   EnsemblMetazoa; FBtr0089509; FBpp0088501; FBgn0002921. [P13607-2]
DR   EnsemblMetazoa; FBtr0089510; FBpp0088502; FBgn0002921. [P13607-1]
DR   EnsemblMetazoa; FBtr0089511; FBpp0088503; FBgn0002921. [P13607-2]
DR   EnsemblMetazoa; FBtr0089512; FBpp0088504; FBgn0002921. [P13607-3]
DR   EnsemblMetazoa; FBtr0089513; FBpp0088984; FBgn0002921. [P13607-2]
DR   EnsemblMetazoa; FBtr0089514; FBpp0088983; FBgn0002921. [P13607-6]
DR   EnsemblMetazoa; FBtr0089515; FBpp0088982; FBgn0002921. [P13607-7]
DR   EnsemblMetazoa; FBtr0089516; FBpp0088981; FBgn0002921. [P13607-6]
DR   EnsemblMetazoa; FBtr0333324; FBpp0305516; FBgn0002921. [P13607-2]
DR   EnsemblMetazoa; FBtr0333325; FBpp0305517; FBgn0002921. [P13607-2]
DR   GeneID; 48971; -.
DR   KEGG; dme:Dmel_CG5670; -.
DR   UCSC; CG5670-RE; d. melanogaster.
DR   UCSC; CG5670-RH; d. melanogaster.
DR   CTD; 48971; -.
DR   FlyBase; FBgn0002921; Atpalpha.
DR   VEuPathDB; VectorBase:FBgn0002921; -.
DR   eggNOG; KOG0203; Eukaryota.
DR   InParanoid; P13607; -.
DR   OMA; CYIAYSV; -.
DR   PhylomeDB; P13607; -.
DR   Reactome; R-DME-936837; Ion transport by P-type ATPases.
DR   SignaLink; P13607; -.
DR   BioGRID-ORCS; 48971; 1 hit in 3 CRISPR screens.
DR   ChiTaRS; Atpalpha; fly.
DR   GenomeRNAi; 48971; -.
DR   PRO; PR:P13607; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0002921; Expressed in adult Malpighian tubule (Drosophila) and 24 other tissues.
DR   ExpressionAtlas; P13607; baseline and differential.
DR   Genevisible; P13607; DM.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:FlyBase.
DR   GO; GO:0005737; C:cytoplasm; HDA:FlyBase.
DR   GO; GO:0005634; C:nucleus; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0005918; C:septate junction; IDA:FlyBase.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; IDA:FlyBase.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0019829; F:ATPase-coupled cation transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005391; F:P-type sodium:potassium-exchanging transporter activity; IDA:FlyBase.
DR   GO; GO:0008344; P:adult locomotory behavior; IMP:FlyBase.
DR   GO; GO:0006812; P:cation transport; IDA:FlyBase.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0006883; P:cellular sodium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; IDA:FlyBase.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:FlyBase.
DR   GO; GO:0007630; P:jump response; IMP:FlyBase.
DR   GO; GO:0007626; P:locomotory behavior; IMP:FlyBase.
DR   GO; GO:0050905; P:neuromuscular process; IMP:FlyBase.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:1902600; P:proton transmembrane transport; IBA:GO_Central.
DR   GO; GO:0035158; P:regulation of tube diameter, open tracheal system; IMP:FlyBase.
DR   GO; GO:0035159; P:regulation of tube length, open tracheal system; IMP:FlyBase.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:FlyBase.
DR   GO; GO:0009266; P:response to temperature stimulus; IMP:FlyBase.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:FlyBase.
DR   GO; GO:0019991; P:septate junction assembly; IMP:FlyBase.
DR   GO; GO:0036376; P:sodium ion export across plasma membrane; IBA:GO_Central.
DR   GO; GO:0051124; P:synaptic assembly at neuromuscular junction; IMP:FlyBase.
DR   GO; GO:0001894; P:tissue homeostasis; IMP:FlyBase.
DR   GO; GO:0060439; P:trachea morphogenesis; IMP:FlyBase.
DR   CDD; cd02608; P-type_ATPase_Na-K_like; 1.
DR   Gene3D; 3.40.1110.10; -; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR005775; P-type_ATPase_IIC.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   SUPFAM; SSF81653; SSF81653; 1.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   SUPFAM; SSF81665; SSF81665; 1.
DR   TIGRFAMs; TIGR01106; ATPase-IIC_X-K; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 2.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Ion transport; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Potassium; Potassium transport;
KW   Reference proteome; RNA editing; Sodium; Sodium transport;
KW   Sodium/potassium transport; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1041
FT                   /note="Sodium/potassium-transporting ATPase subunit alpha"
FT                   /id="PRO_0000046309"
FT   TRANSMEM        115..135
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        147..167
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        312..332
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        338..358
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        808..828
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        870..890
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        935..955
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        970..990
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        394
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000305"
FT   BINDING         526
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..39
FT                   /note="Missing (in isoform 2, isoform 3, isoform 6 and
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:12537569,
FT                   ECO:0000303|PubMed:9648860"
FT                   /id="VSP_000417"
FT   VAR_SEQ         1..8
FT                   /note="MALRSDYE -> MSAQ (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_008074"
FT   VAR_SEQ         835..865
FT                   /note="VPAISLAYEHAEADIMKRPPRDPFNDKLVNS -> IPAISLAYEGPEADIMK
FT                   RRPRNPEIDNLVNE (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_008075"
FT   VAR_SEQ         835..865
FT                   /note="VPAISLAYEHAEADIMKRPPRDPFNDKLVNS -> IPAISLAYEQAESDIMK
FT                   RQPRDPYRDNLVNR (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_008076"
FT   VAR_SEQ         836..878
FT                   /note="PAISLAYEHAEADIMKRPPRDPFNDKLVNSRLISMAYGQIGMI -> SLDLC
FT                   PKPKLHRRLKLKLLLSQYHSSKLYSYTSCSPSQLIVKN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12537569"
FT                   /id="VSP_008077"
FT   VAR_SEQ         844..865
FT                   /note="HAEADIMKRPPRDPFNDKLVNS -> TAESDIMKRQPRNPFQDKLVNE (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000418"
FT   VAR_SEQ         879..1041
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12537569"
FT                   /id="VSP_008078"
FT   VARIANT         429
FT                   /note="Y -> C (in RNA edited version)"
FT   MUTAGEN         1020
FT                   /note="D->N: In allele ATP-alpha-dts2; homozygous lethal
FT                   and temperature dependent bang sensitive paralysis,
FT                   shortened life span and neurodegeneration when
FT                   heterozygous."
FT                   /evidence="ECO:0000269|PubMed:12598616"
FT   MUTAGEN         1021
FT                   /note="E->K: In allele ATP-alpha-dts1; homozygous lethal
FT                   and temperature dependent bang sensitive paralysis,
FT                   shortened life span and neurodegeneration when
FT                   heterozygous."
FT                   /evidence="ECO:0000269|PubMed:12598616"
FT   CONFLICT        69
FT                   /note="L -> M (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        85
FT                   /note="K -> R (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        97
FT                   /note="Missing (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112..113
FT                   /note="KN -> ED (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        117..118
FT                   /note="GF -> V (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        163
FT                   /note="I -> V (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        192
FT                   /note="E -> G (in Ref. 2; AAC05260)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        196..197
FT                   /note="LT -> PS (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207..208
FT                   /note="DV -> VL (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211..212
FT                   /note="VK -> LE (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216..221
FT                   /note="RIPADI -> LIPLVY (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="N -> D (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270..272
FT                   /note="GTA -> ALP (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        290
FT                   /note="G -> A (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        299
FT                   /note="Missing (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="N -> T (in Ref. 8; CAA35504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        488
FT                   /note="I -> N (in Ref. 8; CAA35504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        811
FT                   /note="F -> S (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        843
FT                   /note="E -> D (in Ref. 1; CAA32638)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1041 AA;  115605 MW;  B2DD36B2E9029F43 CRC64;
     MALRSDYEHG RADSYRVATV IATDDDNRTA DGQYKSRRKM PAKVNKKENL DDLKQELDID
     FHKISPEELY QRFQTHPENG LSHAKAKENL ERDGPNALTP PKQTPEWVKF CKNLFGGFAM
     LLWIGAILCF VAYSIQASTS EEPADDNLYL GIVLSAVVIV TGIFSYYQES KSSKIMESFK
     NMVPQFATVI REGEKLTLRA EDLVLGDVVE VKFGDRIPAD IRIIEARNFK VDNSSLTGES
     EPQSRGAEFT HENPLETKNL AFFSTNAVEG TAKGVVISCG DHTVMGRIAG LASGLDTGET
     PIAKEIHHFI HLITGVAVFL GVTFFVIAFI LGYHWLDAVI FLIGIIVANV PEGLLATVTV
     CLTLTAKRMA SKNCLVKNLE AVETLGSTST ICSDKTGTLT QNRMTVAHMW FDNQIIEADT
     TEDQSGVQYD RTSPGFKALS RIATLCNRAE FKGGQDGVPI LKKEVSGDAS EAALLKCMEL
     ALGDVMNIRK RNKKIAEVPF NSTNKYQVSI HETEDTNDPR YLLVMKGAPE RILERCSTIF
     INGKEKVLDE EMKEAFNNAY MELGGLGERV LGFCDFMLPS DKYPNGFKFN TDDINFPIDN
     LRFVGLMSMI DPPRAAVPDA VAKCRSAGIK VIMVTGDHPI TAKAIAKSVG IISEGNETVE
     DIAQRLNIPV SEVNPREAKA AVVHGAELRD VSSDQLDEIL RYHTEIVFAR TSPQQKLIIV
     EGCQRMGAIV AVTGDGVNDS PALKKADIGV AMGIAGSDVS KQAADMILLD DNFASIVTGV
     EEGRLIFDNL KKSIAYTLTS NIPEISPFLA FILCDIPLPL GTVTILCIDL GTDMVPAISL
     AYEHAEADIM KRPPRDPFND KLVNSRLISM AYGQIGMIQA AAGFFVYFVI MAENGFLPKK
     LFGIRKMWDS KAVNDLTDSY GQEWTYRDRK TLEYTCHTAF FISIVVVQWA DLIICKTRRN
     SIFQQGMRNW ALNFGLVFET VLAAFLSYCP GMEKGLRMYP LKLVWWFPAI PFALAIFIYD
     ETRRFYLRRN PGGWLEQETY Y
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024